These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7834645)

  • 21. Metabolic and biochemical issues in the molecular epidemiology of cancer.
    Snyder R; Hong JY
    IARC Sci Publ; 2004; (157):51-69. PubMed ID: 15055290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dihaloalkanes and polyhaloalkenes.
    Guengerich FP; Min KS; Persmark M; Kim MS; Humphreys WG; Cmarik JM; Thier R
    IARC Sci Publ; 1994; (125):57-72. PubMed ID: 7806341
    [No Abstract]   [Full Text] [Related]  

  • 23. [Relationship between the gene polymorphisms of oxidative metabolism enzyme of exogenous chemicals and the susceptibility to neoplasms].
    Xia G; Hu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 42(12):1439-1446. PubMed ID: 29317586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
    Blair IA; Oe T; Kambouris S; Chaudhary AK
    Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contributions from molecular/biochemical approaches in epidemiology to cancer risk assessment and prevention.
    Lohman PH; Morolli B; Darroudi F; Natarajan AT; Gossen JA; Venema J; Mullenders LH; Vogel EW; Vrieling H; van Zeeland AA
    Environ Health Perspect; 1992 Nov; 98():155-65. PubMed ID: 1486845
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of individual susceptibility in cancer burden related to environmental exposure.
    Bartsch H; Hietanen E
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):569-77. PubMed ID: 8781385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of cytochrome P-450 genetic polymorphisms in oral carcinogenesis.
    Hernando-Rodriguez M; Rey-Barja N; Marichalar-Mendia X; Rodriguez-Tojo MJ; Acha-Sagredo A; Aguirre-Urizar JM
    J Oral Pathol Med; 2012 Jan; 41(1):1-8. PubMed ID: 21793938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Individual predisposition to lung neoplasm--the role of genes involved in metabolism of carcinogens].
    Butkiewicz D; Chorazy M
    Postepy Hig Med Dosw; 1999; 53(5):655-73. PubMed ID: 10645142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism.
    Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R
    Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemical carcinogenic substances in food products of plant origin (a review of the literature)].
    Neĭman IM
    Vopr Pitan; 1978; (1):55-60. PubMed ID: 629032
    [No Abstract]   [Full Text] [Related]  

  • 32. Series: current issues in mutagenesis and carcinogenesis, No. 66. Lijinsky's observation that the spontaneous tumour incidence in F334 rats is unaffected by prior damage to DNA.
    Ashby J
    Mutat Res; 1996 Feb; 349(2):289-90. PubMed ID: 8600358
    [No Abstract]   [Full Text] [Related]  

  • 33. Perinatal and multigenerational effect of carcinogens: possible contribution to determination of cancer susceptibility.
    Yamasaki H; Loktionov A; Tomatis L
    Environ Health Perspect; 1992 Nov; 98():39-43. PubMed ID: 1486860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary polymorphisms of human drug metabolizing enzymes and cancer susceptibility.
    Gonzalez FJ
    Birth Defects Orig Artic Ser; 1990; 26(1):17-42. PubMed ID: 2224077
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic polymorphism of cytochrome P450 as a biomarker of susceptibility to environmental toxicity.
    Hong JY; Yang CS
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):759-62. PubMed ID: 9255558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA adducts, mutations and cancer.
    Hemminki K
    Carcinogenesis; 1993 Oct; 14(10):2007-12. PubMed ID: 8222046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes.
    Shields PG; Bowman ED; Harrington AM; Doan VT; Weston A
    Cancer Res; 1993 Aug; 53(15):3486-92. PubMed ID: 8339251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk evaluation of carcinogens and their threshold levels, part III].
    Neumann HG
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Sep; 49(9):911-20. PubMed ID: 16937321
    [No Abstract]   [Full Text] [Related]  

  • 40. Chapter 14. Ah receptor gene polymorphisms and human cancer susceptibility.
    Garte S; Sogawa K
    IARC Sci Publ; 1999; (148):149-57. PubMed ID: 10493256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.